SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-17-089656
Filing Date
2017-03-21
Accepted
2017-03-20 19:33:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d347127dsc13da.htm SC 13D/A 30629
2 EX-99.3 d347127dex993.htm EX-99.3 29379
3 EX-99.4 d347127dex994.htm EX-99.4 4610
  Complete submission text file 0001193125-17-089656.txt   66192
Mailing Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931
Business Address 7327 OAK RIDGE HWY SUITE B KNOXVILLE TN 37931 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Subject) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-32172 | Film No.: 17702647
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7327 OAK RIDGE HWY SUITE A OAK RIGE TN 37931
Business Address
CULPEPPER PETER R (Filed by) CIK: 0001281041 (see all company filings)

Type: SC 13D/A